Silo Pharma shares rise 29.62% premarket after announcing $1M share buyback program.

Silo Pharma (NASDAQ: SILO) surged 29.62% in premarket trading following the announcement of a $1 million share repurchase program on February 23, 2026. The board-authorized initiative allows the company to buy shares on the open market or via private transactions, reflecting management’s confidence in the stock’s intrinsic value. The CEO highlighted that current market conditions present an opportunity to enhance shareholder value, aligning with the positive price reaction. The program, which does not obligate the company to repurchase a specific number of shares, was cited as the primary catalyst across multiple news reports, including after-hours trading surges of 35.14% earlier in the week. While technical analysis noted weak volume, the buyback itself remains the key driver of the premarket rally.